Literature DB >> 21046403

Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.

Sung Yoon Park1, Chan Kyo Kim, Byung Kwan Park, Hyun Moo Lee, Kyung Soo Lee.   

Abstract

OBJECTIVE: To retrospectively assess the apparent diffusion coefficient (ADC) as a predictor of biochemical recurrence (BCR) after surgery in patients with localised prostate cancer.
METHODS: Enrolled in this study were 158 men who underwent surgery between 2005 and 2007 with preoperative diffusion-weighted MR imaging (DWI) at 3 T, and who received follow-up for a median of 24 months (range, 12-57 months). Univariate and multivariate analyses including all clinical variables and tumour ADC data were performed with respect to BCR. Receiver operating characteristic (ROC) analysis was also performed to assess diagnostic performance of variables in the prediction of BCR.
RESULTS: Thirty patients (19%) who received surgery had BCR. Univariate analysis revealed that tumour ADC, Gleason score at biopsy and surgical specimen, serum PSA, greatest percentage of cancer in biopsy core, percentage of positive cores in all biopsy cores and tumour volume were all significantly related to BCR. However, multivariate analysis identified tumour ADC as the only independently predictive factor. For predicting BCR, area under the curve for tumour ADC was 0.755, and tumour ADC showed better diagnostic performance than that of all other variables.
CONCLUSION: Tumour ADC on DWI may be a predictive biomarker for BCR following radical prostatectomy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21046403     DOI: 10.1007/s00330-010-1999-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients.

Authors:  S F Riches; K Hawtin; E M Charles-Edwards; N M de Souza
Journal:  NMR Biomed       Date:  2009-04       Impact factor: 4.044

2.  Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

Authors:  Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

3.  Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.

Authors:  Stephen J Freedland; Elizabeth B Humphreys; Leslie A Mangold; Mario Eisenberger; Alan W Partin
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

4.  Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.

Authors:  Andrew J Stephenson; Michael W Kattan; James A Eastham; Zohar A Dotan; Fernando J Bianco; Hans Lilja; Peter T Scardino
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

5.  Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.

Authors:  Ryuji Murakami; Takeshi Sugahara; Hideo Nakamura; Toshinori Hirai; Mika Kitajima; Yoshiko Hayashida; Yuji Baba; Natsuo Oya; Jun-Ichi Kuratsu; Yasuyuki Yamashita
Journal:  Radiology       Date:  2007-03-13       Impact factor: 11.105

6.  Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.

Authors:  Jochen Walz; Felix K-H Chun; Eric A Klein; Alwyn Reuther; Fred Saad; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
Journal:  J Urol       Date:  2008-12-13       Impact factor: 7.450

7.  Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.

Authors:  Liang Wang; Hedvig Hricak; Michael W Kattan; Lawrence H Schwartz; Steven C Eberhardt; Hui-Ni Chen; Peter T Scardino
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

8.  Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study.

Authors:  Hyun Kyung Lim; Jeong Kon Kim; Kyung Ah Kim; Kyoung-Sik Cho
Journal:  Radiology       Date:  2008-11-18       Impact factor: 11.105

9.  Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.

Authors:  Rajpal Dhingsa; Aliya Qayyum; Fergus V Coakley; Ying Lu; Kirk D Jones; Mark G Swanson; Peter R Carroll; Hedvig Hricak; John Kurhanewicz
Journal:  Radiology       Date:  2004-01       Impact factor: 11.105

10.  Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.

Authors:  N M deSouza; S F Riches; N J Vanas; V A Morgan; S A Ashley; C Fisher; G S Payne; C Parker
Journal:  Clin Radiol       Date:  2008-04-18       Impact factor: 2.350

View more
  25 in total

Review 1.  Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts.

Authors:  Hee Kang; Ho Yun Lee; Kyung Soo Lee; Jae-Hun Kim
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

2.  Do tumor volume, percent tumor volume predict biochemical recurrence after radical prostatectomy? A meta-analysis.

Authors:  Yang Meng; He Li; Peng Xu; Jia Wang
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 3.  Functional MRI and CT biomarkers in oncology.

Authors:  J M Winfield; G S Payne; N M deSouza
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-13       Impact factor: 9.236

4.  Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients.

Authors:  Tae Heon Kim; Chan Kyo Kim; Byung Kwan Park; Hwang Gyun Jeon; Byung Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

5.  Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.

Authors:  Tae Heon Kim; Jae Yong Jeong; Sin Woo Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

Review 6.  Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers.

Authors:  Matthew J Watson; Arvin K George; Mahir Maruf; Thomas P Frye; Akhil Muthigi; Michael Kongnyuy; Subin G Valayil; Peter A Pinto
Journal:  Future Oncol       Date:  2016-07-12       Impact factor: 3.404

Review 7.  The emerging role of diffusion-weighted MRI in prostate cancer management.

Authors:  Edward M Lawrence; Vincent J Gnanapragasam; Andrew N Priest; Evis Sala
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

8.  Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.

Authors:  Nelly Tan; Luyao Shen; Pooria Khoshnoodi; Héctor E Alcalá; Weixia Yu; William Hsu; Robert E Reiter; David Y Lu; Steven S Raman
Journal:  J Urol       Date:  2017-11-08       Impact factor: 7.450

9.  The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer.

Authors:  Yu-Dong Zhang; Qing Wang; Chen-Jiang Wu; Xiao-Ning Wang; Jing Zhang; Hui Liu; Xi-Sheng Liu; Hai-Bin Shi
Journal:  Eur Radiol       Date:  2014-11-28       Impact factor: 5.315

10.  Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.

Authors:  Sung Yoon Park; Young Taik Oh; Dae Chul Jung; Nam Hoon Cho; Young Deuk Choi; Koon Ho Rha; Sung Joon Hong
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.